134 related articles for article (PubMed ID: 36762743)
21. Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis.
Menez S; Hruskova Z; Scott J; Cormican S; Chen M; Salama AD; Alasfar S; Little MA; Safrankova H; Honsova E; Tesar V; Geetha D
Am J Nephrol; 2018; 48(6):465-471. PubMed ID: 30472700
[TBL] [Abstract][Full Text] [Related]
22. Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival.
Lin W; Shen C; Zhong Y; Ooi JD; Eggenhuizen P; Zhou YO; Luo H; Huang J; Chen JB; Wu T; Meng T; Xiao Z; Ao X; Peng W; Tang R; Yin H; Xiao X; Zhou Q; Xiao P
Front Immunol; 2021; 12():625672. PubMed ID: 33841408
[TBL] [Abstract][Full Text] [Related]
23. Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.
Yoo BW; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Rheumatol; 2020 Mar; 39(3):831-840. PubMed ID: 31802348
[TBL] [Abstract][Full Text] [Related]
24. Clinical and Renal Histology Findings and Different Responses to Induction Treatment Affecting the Long-Term Renal Outcomes of Children With ANCA-Associated Vasculitis: a Single-Center Cohort Analysis.
Yang J; Yang Y; Xu Y; Zhou L; Zhou L; Yin X; Pu J; Yang F; Liu Y; He Y; Chen Y; Yuan H; Qiu L; Zhang Y; Chen Y; Liu T; Tang J; Zhou J
Front Immunol; 2022; 13():857813. PubMed ID: 35493514
[TBL] [Abstract][Full Text] [Related]
25. Assessment of Renal Risk Score and Histopathological Classification for Prediction of End-Stage Kidney Disease and Factors Associated With Change in eGFR After ANCA-Glomerulonephritis Diagnosis.
Brilland B; Boud'hors C; Copin MC; Jourdain P; Henry N; Wacrenier S; Djema A; Samoreau C; Coindre JP; Cousin M; Riou J; Croue A; Saint-André JP; Subra JF; Piccoli GB; Augusto JF
Front Immunol; 2022; 13():834878. PubMed ID: 35392077
[TBL] [Abstract][Full Text] [Related]
26. High anti-neutrophil cytoplasmic antibody titers are associated with the requirement of permanent dialysis in patients with myeloperoxidase-ANCA-associated vasculitis.
Yen CL; Tian YC; Wu HH; Tu KH; Liu SH; Lee CC; Fang JT; Yang CW; Li YJ
J Formos Med Assoc; 2019 Oct; 118(10):1408-1415. PubMed ID: 31133523
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcomes of Japanese MPO-ANCA-related nephritis: significance of initial renal death for survival.
Watanabe K; Tani Y; Kimura H; Tanaka K; Hayashi Y; Asahi K; Sato K; Sato M; Matsushima M; Nakayama M; Watanabe T
Intern Med; 2012; 51(15):1969-76. PubMed ID: 22864120
[TBL] [Abstract][Full Text] [Related]
28. Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients.
Hu X; Shen C; Meng T; Ooi JD; Eggenhuizen PJ; Zhou YO; Luo H; Chen JB; Lin W; Gong Y; Xiong Q; Xu J; Liu N; Xiao X; Tang R; Zhong Y
Front Immunol; 2022; 13():991469. PubMed ID: 36389826
[TBL] [Abstract][Full Text] [Related]
29. The risk factors for early mortality and end-stage renal disease in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: experiences from a single center.
Ni A; Chen L; Huang X; Ma Y; Lan L; Ren P; Wang Y; Zhu Y; Xu Y; Chen J; Han F
Clin Exp Med; 2021 Aug; 21(3):389-397. PubMed ID: 33768341
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics and outcomes of MPO-ANCA-associated glomerulonephritis with bronchiectasis: A retrospective case-control study.
Luo L; Li H; Tang J; Liao Z; Wang F; Jin Y; Zhou F; Feng J; Li X
Semin Arthritis Rheum; 2022 Dec; 57():152082. PubMed ID: 36058136
[TBL] [Abstract][Full Text] [Related]
31. Determinants of renal and patient outcomes in a Spanish cohort of patients with ANCA-associated vasculitis and renal involvement.
Marco H; Draibe J; Villacorta J; Quintana LF; Martin N; Garcia-Osuna R; Cabre C; Martín-Gómez MA; Balius A; Saurina A; Picazo M; Gich-Saladich I; Navarro-Díaz M; Praga M; Cavero T; Ballarin J; Díaz-Encarnación MM;
Clin Rheumatol; 2018 Apr; 37(4):1065-1074. PubMed ID: 29520673
[TBL] [Abstract][Full Text] [Related]
32. Predictors of renal outcomes in anti-neutrophil cytoplasmic antibody glomerulonephritis.
Jebali H; Khadhar M; Mami I; Beji S; Sellami M; Hassen M; Hmida FB; Chermiti M; Ghabi H; Salem TB; Houman H; Raies L; Zouaghi MK
Saudi J Kidney Dis Transpl; 2020; 31(1):182-190. PubMed ID: 32129212
[TBL] [Abstract][Full Text] [Related]
33. The Dutch Transplantation in Vasculitis (DUTRAVAS) Study: Outcome of Renal Transplantation in Antineutrophil Cytoplasmic Antibody-associated Glomerulonephritis.
Göçeroğlu A; Rahmattulla C; Berden AE; Reinders ME; Wolterbeek R; Steenbergen EJ; Hilbrands LB; Noorlander I; Berger SP; Peutz-Kootstra CJ; Christiaans MH; van Dijk MC; de Joode AA; Goldschmeding R; van Zuilen AD; Harper L; Little MA; Hagen EC; Bruijn JA; Bajema IM
Transplantation; 2016 Apr; 100(4):916-24. PubMed ID: 26371598
[TBL] [Abstract][Full Text] [Related]
34. Clinical and histopathological prognostic factors affecting the renal outcomes in childhood ANCA-associated vasculitis.
Özçelik G; Sönmez HE; Şahin S; Özağarı A; Bayram MT; Çiçek RY; Çakıcı EK; Çomak E; Barut K; Şahin N; Bakkaloğlu S; Gökçe İ; Düzova A; Bilginer Y; Açarı C; Melek E; Kılıç BD; Özdel S; Adroviç A; Kasapçopur Ö; Ünsal E; Alpay H; Orhan D; Topaloğlu R; Düşünsel R; Özen S
Pediatr Nephrol; 2019 May; 34(5):847-854. PubMed ID: 30607566
[TBL] [Abstract][Full Text] [Related]
35. An evaluation of the 2010 histopathological classification of anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis: a Bayesian network meta-analysis.
Huang S; Shen Q; Yang R; Lai H; Zhang J
Int Urol Nephrol; 2018 Oct; 50(10):1853-1861. PubMed ID: 30046964
[TBL] [Abstract][Full Text] [Related]
36. The survival nomograms for anti-neutrophil cytoplasmic antibody-associated glomerulonephritis patients with a follow-up of more than one year.
Chen L; Ni A; Huang X; Ren P; Lan L; Wang Y; Zhu Y; Xu Y; Chen J; Han F
Clin Exp Rheumatol; 2022 May; 40(4):793-800. PubMed ID: 35200128
[TBL] [Abstract][Full Text] [Related]
37. Impact of Proteinase 3 versus Myeloperoxidase Positivity on Risk of End-Stage Renal Disease in ANCA-Associated Glomerulonephritis Stratified by Histological Classification: A Population-Based Cohort Study.
Solbakken V; Fismen AS; Bostad L; Bjørneklett R
Dis Markers; 2018; 2018():3251517. PubMed ID: 29854025
[TBL] [Abstract][Full Text] [Related]
38. Evaluating renal outcome of ANCA-associated renal vasculitis: comparative study of two histopathological scoring systems.
An XN; Wei ZN; Yao XY; Xu J; Qian WT; Pan XX; Shen PY; Shi H; Zhang W; Chen XN; Chen N; Chen YX
Clin Exp Rheumatol; 2021; 39 Suppl 129(2):39-45. PubMed ID: 33337988
[TBL] [Abstract][Full Text] [Related]
39. Myeloperoxidase anti-neutrophil cytoplasmic antibody affinity is associated with the formation of neutrophil extracellular traps in the kidney and vasculitis activity in myeloperoxidase anti-neutrophil cytoplasmic antibody-associated microscopic polyangiitis.
Yoshida M; Yamada M; Sudo Y; Kojima T; Tomiyasu T; Yoshikawa N; Oda T; Yamada M
Nephrology (Carlton); 2016 Jul; 21(7):624-9. PubMed ID: 26833773
[TBL] [Abstract][Full Text] [Related]
40. Anti-myeloperoxidase and proteinase 3 antibodies for nephritis flare prediction in anti-neutrophil cytoplasmic antibody-associated vasculitis.
Rodríguez E; Latzke B; Sierra M; Romera AM; Siedel D; Agraz I; Soler MJ; García-Carro C; Draibe J; de la Prada FJ; Villacorta J; Buxeda A; Sierra-Ochoa A; Lozano I; Durán X; Barrios C; Pascual J
Nephrol Dial Transplant; 2022 Mar; 37(4):697-704. PubMed ID: 33533909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
